¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"molecular lesion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • molecular weight
    ºÐÀÚ·®
  • molecular weight determination
    ºÐÀÚ·®ÃøÁ¤
  • butterfly lesion
    ³ªºñº´ÅÍ
  • coin lesion
    µ¿Àüº´ÅÍ
  • cystic lesion
    ³¶º´ÅÍ, ÁָӴϺ´ÅÍ
  • destructive lesion
    ÆÄ±«º´ÅÍ
  • echogenic lesion
    ¸Þ¾Æ¸®¹ß»ýº´ÅÍ, ¿¡Äڹ߻ýº´ÅÍ
  • epileptogenic lesion
    °£ÁúÀ¯¹ßº´ÅÍ, °£ÁúÀ¯¹ßº´º¯
  • focal lesion
    ±¹¼Òº´ÅÍ
  • gelatinous lesion
    Á©¶óƾ¸ð¾çº´ÅÍ
  • high-grade squamous intraepithelial lesion
    °íµî±ÞÆíÆò»óÇdz»º´ÅÍ
  • impaction lesion
    ¸Åº¹º´ÅÍ
  • inflammatory lesion
    ¿°Áõº´ÅÍ, ¿°ÁõȯºÎ
  • keratotic lesion
    °¢È­º´ÅÍ
  • lesion
    1. º´ÅÍ, º´º¯, º´¼Ò 2. ¼Õ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • molecular weight
    ºÐÀÚ·®
  • molecular air pump
    ºÐÀڽİø±âÆßÇÁ
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇа˻ç
  • molecular tumbling rate
    ºÐÀÚÅÒºí¸µ·ü
  • molecular weight modifier
    ºÐÀÚ·®Á¶ÀýÁ¦
  • butterfly lesion
    ³ªºñ¸ð¾çº´ÅÍ
  • coin lesion
    µ¿Àü¸ð¾çº´ÅÍ
  • destructive lesion
    ÆÄ±«¼ºº´ÅÍ
  • echogenic lesion
    ¸Þ¾Æ¸®¹ß»ýº´ÅÍ, ¿¡Äڹ߻ýº´ÅÍ
  • epileptogenic lesion
    °£ÁúÀ¯¹ßº´ÅÍ
  • focal lesion
    ±¹¼Òº´ÅÍ
  • gelatinous lesion
    Á©¶óƾ¸ð¾çº´ÅÍ
  • radiofrequeny lesion generator
    °íÁÖÆÄº´Å͹߻ý±â
  • impaction lesion
    ¸Åº¹º´ÅÍ
  • inflammatory lesion
    ¿°Áõº´ÅÍ, ¿°ÁõȯºÎ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary lesion
    ÀÏÂ÷¼º º´º¯(ìéó­àõ ܻܨ), Ãʰ¨¿°¼Ò(ôøÊïæøáµ)
  • punched-out lesion
    µµ·Á³½ º´º¯
  • pyramidal tract lesion
    Ãßü·ÎÀå¾Ö(¡­î¡äô).
  • radial sclerosing lesion
    ¹æ»ç¼º °æÈ­¼º º´º¯
  • retrocochlear lesion
    ÈĹ̷Î(¼º) º´º¯
  • retrocochlear lesion
    ÈĹ̷μº º´º¯(ý­Ú»ÖØàõܻܨ)
  • ribbon lesion
    ¸®º»¾çº´º¯.
  • ribbon lesion
    ¸®º»¾ç º´º¯(¡­åÆÜ»Ü¨)
  • satellite lesion
    À§¼ºº´º¯
  • satellite lesion
    À§¼ºº´º¯(êÛàøÜ»Ü¨)
  • secondary lesion
    ÀÌÂ÷¼ºº´º¯,ÀÌÂ÷¹ßÁø,¼Ó¹ßÁø
  • secondary lesion
    ÀÌÂ÷¼ºº´º¯(ì£ó­àõܻܨ),ÀÌÂ÷¹ßÁø(ì£ó­Û¡òÖ),¼Ó¹ßÁø(áÙÛ¡òÖ)
  • skin lesion
    ÇǺκ´º¯(¡­Ü»Ü¨)
  • soap-bubble lesion
    ºñ´©°Åǰ¾çº´¼Ò(¡­åÆÜ»áµ)
  • solitary lesion
    °í¸³º´º¯(¡­Ü»Ü¨)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • viscosity-average molecular weight
    Á¡µµ(ïÄÓø)Æò±Õ ºÐÀÚ·®(øÁгÝÂí­Õá)
  • weight-average molecular weight
    ¹«°ÔÆò±Õ(øÁг) ºÐÀÚ·®(ÝÂí­Õá)
  • z-average molecular weight
    z Æò±ÕºÐÀÚ·® (øÁгÝÂí­Õá)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IMLNS idiopathic minimal lesion nephrotic syndrome
les lesion
LMNL lower motor neuron lesion
LPL lichen planus-like lesion; lipoprotein lipase
MCL maximum containment laboratory; medial collateral ligament; midclavicular line; midcostal line; mini...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TLR Target lesion revascularization
S lesion
LGSIL low grade squamous intra-epithelial lesion
MW 000-molecular weight
AMOVA Analyses of molecular variance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molecular weight distribution
    ºÐÀÚ·® ºÐÆ÷
  • aphthous lesion
    ¾ÆÇÁŸ¼º º´¼Ò
  • aphthous-aphthoid lesion
    ¾ÆÇÁŸ¼º-¾ÆÇÁŸ¾ç º´¼Ò
  • apical lesion
    Ä¡±Ù´Ü º´¼Ò
  • artificial caries lesion
    Àΰø ¿ì½Ä º´¼Ò
  • benign lymphoepithelial lesion
    ¾ç¼º ¸²ÇÁ »óÇǼº º´¼Ò
    Ÿ¾×¼±ÀÇ ½ÇÁú Á¶Á÷¿¡ ¸²ÇÁ±¸µéÀÌ Ä§À±µÇ¸é¼­ ¼±¹æ ¼¼Æ÷µéÀÌ ÆÄ±«µÇ°í »óÇDZ٠»óÇǵµ¶ó´Â ƯÀÌÇÑ Á¶Á÷ÇÐÀû ±¸Á¶¹°À» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ» ¸»ÇÑ´Ù. Çö¹Ì°æ ¼Ò°ß¿¡¼­´Â ¿±»ó ±¸Á¶´Â Àß º¸Á¸µÇ¾î ÀÖÀ¸¸é¼­ ¿©Æ÷¸¦ °¡Áø ¸²ÇÁ Á¶Á÷ÀÌ Å¸¾×¼±ÀÇ ½ÇÁú Á¶Á÷À» ´ëÄ¡½Ã۰í, ±ºµ¥±ºµ¥¿¡ »êÀçµÇ¾î ÀÖ´Â »óÇDZ٠»óÇǵµµéÀ» º¼ ¼ö ÀÖ´Ù. ±Ù »óÇÇÀÇ Áõ½ÄÀº Áø´ÜÇÐÀûÀ¸·Î Áß¿äÇϸç ÀÌ·± »óÇDZ٠»óÇǵµ³»¿¡ ÀÖ´Â ÃÊÀÚ¾ç ¹°ÁúÀº ¹Ì¼¼±¸Á¶ÀûÀ¸·Î ±âÀú¸· ¹°Áú·Î µÇ¾î ÀÖ´Ù.
  • biochemical lesion
    »ýÈ­ÇÐÀû º´º¯
  • blue superficially situated bulging lesion
    õÃþ û»ö À¶±â º´¼Ò
  • bulging lesion
    À¶±â º´¼Ò
  • bullous lesion
    ¼öÆ÷¼º º´¼Ò
  • bullous-erosive lesion
    ¼öÆ÷-¹Ì¶õ¼º º´¼Ò
  • caries lesion
    ¿ì½Ä º´¼Ò
  • circumscribed lesion
    ±¹ÇѼº º´¼Ò
  • confluent lesion
    À¶ÇÕ¼º º´¼Ò
  • embolic lesion
    »öÀü º´¼Ò
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Duret's lesion Small haemorrhage(s) in the floor of the fourth ventricle or beneath the aqueduct of Sylvius.
(05 Mar 2000)
Janeway lesion One of the stigmata of infectious endocarditis: irregular, erythematous, flat, painless macules on the palms, soles, thenar and hypothenar eminences of the hands, tips of the fingers, and plantar surfaces of the toes; rarely a diffuse rash. In acute endocarditis the lesions may be haemorrhagic or purple.
(05 Mar 2000)
upper motor neuron lesion Injury to cerebral descending (corticonuclear) fibres above the brainstem or spinal motor nerve nucleus.
Synonym: upper motor neuron lesion.
(05 Mar 2000)
Lennert's lesion <tumour> Malignant lymphoma with a high proportion of diffusely scattered epithelioid cells, tonsillar involvement, and an unpredictable course.
Synonym: Lennert's lesion.
(05 Mar 2000)
lesion <pathology> Any pathological or traumatic discontinuity of tissue or loss of function of a part.
Origin: L. Laesio, laedere = to hurt
(18 Nov 1997)
Lohlein-Baehr lesion Focal embolic glomerulonephritis occurring in bacterial endocarditis.
Synonym: Baehr-Lohlein lesion.
(05 Mar 2000)
lower motor neuron lesion Injury to motor cells in the brainstem or spinal cord, or of the axons derived from them.
(05 Mar 2000)
relative molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
gram-molecular weight Molecular weight expressed in grams.
Compare: mole.
(05 Mar 2000)
cloning, molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
(12 Dec 1998)
models, molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
(12 Dec 1998)
molecular <chemistry> Of, pertaining to or composed of molecules: a very small mass of matter.
(18 Nov 1997)
molecular behaviour <psychology> Behaviour described in small response units rather than larger ones; a specific response.
Compare: molar behaviour.
(05 Mar 2000)
molecular biology <study> The study of the biochemistry of cells, it is closely linked to cell biology, in particular the biochemistry of DNA and cogeners.
(16 Dec 1997)
molecular biophysics Biophysics concerned with membrane processes, conformational and configurational properties of macromolecules, bioelectrical phenomena, etc.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á